MedTrace Logo

The Correlation Between B-type Natriuretic Peptide (BNP) and Global End Diastolic Volume

NCT01344265 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2013-04-04

No results posted yet for this study

Summary

The investigators hypothesized that the serum B-type Natriuretic Peptide (BNP) level may be correlated with global end diastolic volume (GEDV) as measured by transpulmonary thermodilution technique (PiCCO). The rationale is that some animal studies have proven that BNP is released from ventricular myocardium in response to physical expansion. Such physical expansion can be measured by GEDV. If the hypothesis can be confirmed with our study, the serum level BNP can be used to monitor volume status of critically ill patient, instead of the invasive monitoring system.

Conditions

  • Critically Ill

Sponsors & Collaborators

  • Jinhua Central Hospital

    lead OTHER

Principal Investigators

  • Zhongheng Zhang, MD · Jinhua Central Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01344265 on ClinicalTrials.gov